Blonanserin
CAS No. 132810-10-7
Blonanserin( AD5423 | Lonasen )
Catalog No. M11308 CAS No. 132810-10-7
Blonanserin is a novel atypical antipsychotic agent with potent dopamine D2 and serotonin 5-HT2 receptors antagonist properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 28 | In Stock |
|
10MG | 43 | In Stock |
|
25MG | 77 | In Stock |
|
50MG | 113 | In Stock |
|
100MG | 158 | In Stock |
|
200MG | 284 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBlonanserin
-
NoteResearch use only, not for human use.
-
Brief DescriptionBlonanserin is a novel atypical antipsychotic agent with potent dopamine D2 and serotonin 5-HT2 receptors antagonist properties.
-
DescriptionBlonanserin is a novel atypical antipsychotic agent with potent dopamine D2 and serotonin 5-HT2 receptors antagonist properties.(In Vitro):Blonanserin exerts some blockade of α1-adrenergic receptors (Ki=26.7 nM) and also shows significant affinity for the D3?receptor (Ki=0.494 nM). Blonanserin possesses low affinity for the sigma receptor (IC50=286 nM), but lacks significant affinity for numerous other sites including the 5-HT1A, 5-HT3, D1, α2-adrenergic, β-adrenergic, H1, and mACh receptors and the monoamine transporters.(In Vivo):Blonanserin (oral gavage; 1 mg/kg; 14 days) significantly ameliorates the social deficit observed in PCP-administered mice and inhibits the decrease in the levels of Ser897-phosphorylation, but preatment with blonanserin does not affect the social behaviors in saline-administered mice.
-
In VitroBlonanserin exerts some blockade of?α1-adrenergic receptors?(Ki=26.7?nM) and also shows significant affinity for the?D3?receptor?(Ki=0.494 nM). Blonanserin possesses low affinity for the?sigma receptor?(IC50=286 nM), but lacks significant?affinity?for numerous other sites including the?5-HT1A,?5-HT3,?D1,?α2-adrenergic,?β-adrenergic,?H1, and?mACh receptors?and the?monoamine transporters.
-
In VivoBlonanserin (oral gavage; 1 mg/kg; 14 days) significantly ameliorates the social deficit observed in PCP-administered mice and inhibits the decrease in the levels of Ser897-phosphorylation, but preatment with blonanserin does not affect the social behaviors in saline-administered mice. Animal Model:Mice received saline or phencyclidine once a day for 14 consecutive days Dosage:1 mg/kg Administration:Oral gavage; 1 mg/kg; 14 days Result:Had an effect on the social deficit in mice that received repeated PCP administration.
-
SynonymsAD5423 | Lonasen
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT2| D2
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number132810-10-7
-
Formula Weight367.5
-
Molecular FormulaC23H30FN3
-
Purity>98% (HPLC)
-
SolubilityEthanol: <1 mg/mL (<1 mM); Water: <1 mg/mL (<1 mM); DMSO: <1 mg/mL (<1 mM)
-
SMILESCCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kawabe K, et al. Clin Neuropharmacol. 2013, Nov-Dec; 36(6):239-4
molnova catalog
related products
-
Lurasidone
Lurasidone is an antagonist of both dopamine D2 and 5-HT7(IC50=1.68 and 0.495 nM, respectively).It also a partial agonist of 5-HT1A receptor(IC50 : 6.75 nM).
-
pCPA methyl ester hy...
pCPA methyl ester hydrochloride is an inhibitor of tryptophan hydroxylase inhibitor and 5-HT synthesis. pCPA methyl ester hydrochloride is permeable across the blood-brain barrier and reduces 5-HT central availability.
-
BRL54443
BRL54443 is a potent, releative selective 5-HT1E/1F agonist with Ki of 2/1 nM, respectively.